The pathogenesis of foot-and-mouth disease in pigs

Frontiers in Veterinary Science

Volumn 3, Issue MAY, 2016, Pages

  Stenfeldt, Carolina ^a,b   Segundo, Fayna Diaz San ^a,c   de los Santos, Teresa ^a   Rodriguez, Luis L ^a   Arzt, Jonathan ^a  

^a PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

^b OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Foot and mouth disease; Foot and mouth disease virus; Host response; Pathogenesis; Pigs; Virology; Virus diseases

Indexed keywords

EID: 85017448942     PISSN: None     EISSN: 22971769     Source Type: Journal    
DOI: 10.3389/fvets.2016.00041     Document Type: Review

References (97)

1. Alexandersen S, Zhang Z, Donaldson AI, Garland AJM. The pathogenesis and diagnosis of foot-and-mouth disease. J Comp Pathol (2003) 129(1):1-36. doi:10.1016/S0021-9975(03)00041-0
2. Arzt J, Baxt B, Grubman MJ, Jackson T, Juleff N, Rhyan J, et al. The pathogenesis of foot-and-mouth disease II: viral pathways in swine, small ruminants, and wildlife; myotropism, chronic syndromes, and molecular virus-host interactions. Transbound Emerg Dis (2011) 58(4):305-26. doi:10.1111/j.1865-1682.2011.01236.x
3. Stenfeldt C, Pacheco JM, Smoliga G, Bishop E, Pauszek S, Hartwig E, et al. Detection of foot-and-mouth disease virus RNA and capsid protein in lymphoid tissues of convalescent pigs does not indicate existence of a carrier state. Transbound Emerg Dis (2014) 63(2):152-64. doi:10.1111/tbed.12235
4. Alexandersen S, Donaldson AI. Further studies to quantify the dose of natural aerosols of foot-and-mouth disease virus for pigs. Epidemiol Infect (2002) 128(2):313-23. doi:10.1017/S0950268801006501
5. Donaldson AI, Alexandersen S. Relative resistance of pigs to infection by natural aerosols of FMD virus. Vet Rec (2001) 148(19):600-2. doi:10.1136/vr.148.19.600
6. Pacheco JM, Gladue DP, Holinka LG, Arzt J, Bishop E, Smoliga G, et al. A partial deletion in non-structural protein 3A can attenuate foot-and-mouth disease virus in cattle. Virology (2013) 446(1-2):260-7. doi:10.1016/j.virol.2013.08.003
7. Yang PC, Chu RM, Chung WB, Sung HT. Epidemiological characteristics and financial costs of the 1997 foot-and-mouth disease epidemic in Taiwan. Vet Rec (1999) 145(25):731-4
8. Dunn CS, Donaldson AI. Natural adaption to pigs of a Taiwanese isolate of foot-and-mouth disease virus. Vet Rec (1997) 141(7):174-5. doi:10.1136/vr.141.7.174
9. Uddowla S, Pacheco JM, Larson C, Bishop E, Rodriguez LL, Rai DK, et al. Characterization of a chimeric foot-and-mouth disease virus bearing a bovine rhinitis B virus leader proteinase. Virology (2013) 447(1-2):172-80. doi:10.1016/j.virol.2013.08.035
10. Donaldson AI. Foot-and-mouth disease in Taiwan. Vet Rec (1997) 140(15):407
11. OIE. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2015: 215 Foot-and-Mouth Disease. Paris: World Organization for Animal Health (2015). p. 145-73
12. Parida S, Fleming L, Oh Y, Mahapatra M, Hamblin P, Gloster J, et al. Reduction of foot-and-mouth disease (FMD) virus load in nasal excretions, saliva and exhaled air of vaccinated pigs following direct contact challenge. Vaccine (2007) 25(45):7806-17. doi:10.1016/j.vaccine.2007.08.058
13. Barnett PV, Cox SJ, Aggarwal N, Gerber H, McCullough KC. Further studies on the early protective responses of pigs following immunisation with high potency foot and mouth disease vaccine. Vaccine (2002) 20(25-26):3197-208. doi:10.1016/S0264-410X(02)00242-6
14. Orsel K, de Jong MC, Bouma A, Stegeman JA, Dekker A. Foot and mouth disease virus transmission among vaccinated pigs after exposure to virus shedding pigs. Vaccine (2007) 25(34):6381-91. doi:10.1016/j.vaccine.2007.06.010
15. de Leeuw PW, Tiessink JW, van Bekkum JG. The challenge of vaccinated pigs with foot-and-mouth disease virus. Zentralbl Veterinarmed B (1979) 26(2):98-109. doi:10.1111/j.1439-0450.1979.tb00798.x
16. Lyoo YS. Experience on outbreaks and controlling FMD in Korea raised a requirement of major modification to establish effective measures to FMD. Global Foot-and-Mouth Disease Research Alliance Scientific Meeting. Hanoi (2015)
17. Terpstra C. Pathogenesis of foot-and-mouth disease in experimentally infected pigs. Bull Off Int Epizoot (1972) 77(5):859-74
18. Fukai K, Yamada M, Morioka K, Ohashi S, Yoshida K, Kitano R, et al. Dose-dependent responses of pigs infected with foot-and-mouth disease virus O/JPN/2010 by the intranasal and intraoral routes. Arch Virol (2015) 160(1):129-39. doi:10.1007/s00705-014-2239-4
19. Stenfeldt C, Pacheco JM, Rodriguez LL, Arzt J. Infection dynamics of foot-and-mouth disease virus in pigs using two novel simulated-natural inoculation methods. Res Vet Sci (2014) 96(2):396-405. doi:10.1016/j.rvsc.2014.01.009
20. Stenfeldt C, Pacheco JM, Rodriguez LL, Arzt J. Early events in the pathogenesis of foot-and-mouth disease in pigs; identification of oropharyngeal tonsils as sites of primary and sustained viral replication. PLoS One (2014) 9(9):e106859. doi:10.1371/journal.pone.0106859
21. Newman JF, Rowlands DJ, Brown F. A physico-chemical sub-grouping of the mammalian picornaviruses. J Gen Virol (1973) 18(2):171-80. doi:10.1099/0022-1317-18-2-171
22. Bachrach HL, Breese SS Jr, Callis JJ, Hess WR, Patty RE. Inactivation of foot-and-mouth disease virus by pH and temperature changes and by formaldehyde. Proc Soc Exp Biol Med (1957) 95(1):147-52. doi:10.3181/00379727-95-23148
23. Arzt J, Pacheco JM, Rodriguez LL. The early pathogenesis of foot-and-mouth disease in cattle after aerosol inoculation: identification of the nasopharynx as the primary site of infection. Vet Pathol (2010) 47(6):1048-63. doi:10.1177/0300985810372509
24. Pacheco JM, Arzt J, Rodriguez LL. Early events in the pathogenesis of foot-and-mouth disease in cattle after controlled aerosol exposure. Vet J (2010) 183(1):46-53. doi:10.1016/j.tvjl.2008.08.023
25. Stenfeldt C, Eschbaumer M, Pacheco JM, Rekant SI, Rodriguez LL, Arzt J. Pathogenesis of primary foot-and-mouth disease virus infection in the nasopharynx of vaccinated and non-vaccinated cattle. PLoS One (2015) 10(11):e0143666. doi:10.1371/journal.pone.0143666
26. Burrows R, Mann JA, Garland AJ, Greig A, Goodridge D. The pathogenesis of natural and simulated natural foot-and-mouth disease infection in cattle. J Comp Pathol (1981) 91(4):599-609. doi:10.1016/0021-9975(81)90089-X
27. Pacheco JM, Mason PW. Evaluation of infectivity and transmission of different Asian foot-and-mouth disease viruses in swine. J Vet Sci (2010) 11(2):133-42. doi:10.4142/jvs.2010.11.2.133
28. van Roermund HJ, Eble PL, de Jong MC, Dekker A. No between-pen transmission of foot-and-mouth disease virus in vaccinated pigs. Vaccine (2010) 28(28):4452-61. doi:10.1016/j.vaccine.2010.04.019
29. Eble P, de Koeijer A, Bouma A, Stegeman A, Dekker A. Quantification of within-and between-pen transmission of foot-and-mouth disease virus in pigs. Vet Res (2006) 37(5):647-54. doi:10.1051/vetres:2006026
30. Pacheco JM, Tucker M, Hartwig E, Bishop E, Arzt J, Rodriguez LL. Direct contact transmission of three different foot-and-mouth disease virus strains in swine demonstrates important strain-specific differences. Vet J (2012) 193(2):456-63. doi:10.1016/j.tvjl.2012.01.012
31. Pacheco JM, Lee KN, Eschbaumer M, Bishop EA, Hartwig EJ, Pauszek SJ, et al. Evaluation of infectivity, virulence and transmission of FDMV field strains of serotypes O and A isolated in 2010 from outbreaks in the Republic of Korea. PLoS One (2016) 11(1):e0146445. doi:10.1371/journal.pone.0146445
32. Quan M, Murphy CM, Zhang Z, Durand S, Esteves I, Doel C, et al. Influence of exposure intensity on the efficiency and speed of transmission of foot-and-mouth disease. J Comp Pathol (2009) 140(4):225-37. doi:10.1016/j.jcpa.2008.12.002
33. Quan M, Murphy CM, Zhang Z, Alexandersen S. Determinants of early foot-and-mouth disease virus dynamics in pigs. J Comp Pathol (2004) 131(4):294-307. doi:10.1016/j.jcpa.2004.05.002
34. Murphy C, Bashiruddin JB, Quan M, Zhang Z, Alexandersen S. Foot-and-mouth disease viral loads in pigs in the early, acute stage of disease. Vet Rec (2010) 166(1):10-4. doi:10.1136/vr.b5583
35. Eble PL, Bouma A, de Bruin MG, van Hemert-Kluitenberg F, van Oirschot JT, Dekker A. Vaccination of pigs two weeks before infection significantly reduces transmission of foot-and-mouth disease virus. Vaccine (2004) 22(11-12):1372-8. doi:10.1016/j.vaccine.2003.11.003
36. Alexandersen S, Oleksiewicz MB, Donaldson AI. The early pathogenesis of foot-and-mouth disease in pigs infected by contact: a quantitative time-course study using TaqMan RT-PCR. J Gen Virol (2001) 82(Pt 4):747-55. doi:10.1099/0022-1317-82-4-747
37. Dias CC, Moraes MP, Segundo FD, de los Santos T, Grubman MJ. Porcine type I interferon rapidly protects swine against challenge with multiple serotypes of foot-and-mouth disease virus. J Interferon Cytokine Res (2011) 31(2):227-36. doi:10.1089/jir.2010.0055
38. Diaz-San Segundo F, Moraes MP, de Los Santos T, Dias CC, Grubman MJ. Interferon-induced protection against foot-and-mouth disease virus infection correlates with enhanced tissue-specific innate immune cell infiltration and interferon-stimulated gene expression. J Virol (2010) 84(4):2063-77. doi:10.1128/JVI.01874-09
39. Pacheco JM, Butler JE, Jew J, Ferman GS, Zhu J, Golde WT. IgA antibody response of swine to foot-and-mouth disease virus infection and vaccination. Clin Vaccine Immunol (2010) 17(4):550-8. doi:10.1128/CVI.00429-09
40. Brown CC, Olander HJ, Meyer RF. Pathogenesis of foot-and-mouth disease in swine, studied by in-situ hybridization. J Comp Pathol (1995) 113(1):51-8. doi:10.1016/S0021-9975(05)80068-4
41. Horter DC, Yoon KJ, Zimmerman JJ. A review of porcine tonsils in immunity and disease. Anim Health Res Rev (2003) 4(2):143-55. doi:10.1079/AHRR200358
42. Grau FR, Schroeder ME, Mulhern EL, McIntosh MT, Bounpheng MA. Detection of African swine fever, classical swine fever, and foot-and-mouth disease viruses in swine oral fluids by multiplex reverse transcription real-time polymerase chain reaction. J Vet Diagn Invest (2015) 27(2):140-9. doi:10.1177/1040638715574768
43. Alexandersen S, Quan M, Murphy C, Knight J, Zhang Z. Studies of quantitative parameters of virus excretion and transmission in pigs and cattle experimentally infected with foot-and-mouth disease virus. J Comp Pathol (2003) 129(4):268-82. doi:10.1016/S0021-9975(03)00045-8
44. Donaldson AI, Alexandersen S, Sorensen JH, Mikkelsen T. Relative risks of the uncontrollable (airborne) spread of FMD by different species. Vet Rec (2001) 148(19):602-4. doi:10.1136/vr.148.19.602
45. Donaldson AI, Herniman KA, Parker J, Sellers RF. Further investigations on the airborne excretion of foot-and-mouth disease virus. J Hyg (Lond) (1970) 68(4):557-64. doi:10.1017/S0022172400042480
46. Sellers RF. Quantitative aspects of the spread of foot and mouth disease. Vet Bull (1971) 41(6):431-9
47. Donaldson AI, Ferris NP. Sites of release of airborne foot-and-mouth disease virus from infected pigs. Res Vet Sci (1980) 29(3):315-9
48. Eble PL, de Bruin MG, Bouma A, van Hemert-Kluitenberg F, Dekker A. Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs. Vaccine (2006) 24(9):1274-81. doi:10.1016/j.vaccine.2005.09.040
49. Rodriguez-Calvo T, Diaz-San Segundo F, Sanz-Ramos M, Sevilla N. A replication analysis of foot-and-mouth disease virus in swine lymphoid tissue might indicate a putative carrier stage in pigs. Vet Res (2011) 42(1):22. doi:10.1186/1297-9716-42-22
50. Mezencio JM, Babcock GD, Kramer E, Brown F. Evidence for the persistence of foot-and-mouth disease virus in pigs. Vet J (1999) 157(3):213-7. doi:10.1053/tvjl.1999.0357
51. Mohamed F, Swafford S, Petrowski H, Bracht A, Schmit B, Fabian A, et al. Foot-and-mouth disease in feral swine: susceptibility and transmission. Transbound Emerg Dis (2011) 58(4):358-71. doi:10.1111/j.1865-1682.2011.01213.x
52. Orsel K, Roest HI, Elzinga-Bril EM, van Hemert-Kluitenberg F, Dekker A. Detection of foot-and-mouth disease virus in infected pigs by RT-PCR four weeks after challenge. Vet Rec (2008) 162(23):753-4. doi:10.1136/vr.162.23.753
53. Zhang Z, Bashiruddin JB. Quantitative analysis of foot-and-mouth disease virus RNA duration in tissues of experimentally infected pigs. Vet J (2009) 180(1):130-2. doi:10.1016/j.tvjl.2007.11.010
54. Lohse L, Jackson T, Botner A, Belsham GJ. Capsid coding sequences of foot-and-mouth disease viruses are determinants of pathogenicity in pigs. Vet Res (2012) 43:46. doi:10.1186/1297-9716-43-46
55. Wilna V, Hong NT, Geoffrey FT, Jacqueline MM, Jianning W, Van Phuc K, et al. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with a FMDV O Mya98 lineage virus in pigs 4 and 7 days post vaccination. Vaccine (2015) 33(24):2778-85. doi:10.1016/j.vaccine.2015.04.045
56. Gulbahar MY, Davis WC, Guvenc T, Yarim M, Parlak U, Kabak YB. Myocarditis associated with foot-and-mouth disease virus type O in lambs. Vet Pathol (2007) 44(5):589-99. doi:10.1354/vp.44-5-589
57. Karapinar T, Dabak DO, Kuloglu T, Bulut H. High cardiac troponin I plasma concentration in a calf with myocarditis. Can Vet J (2010) 51(4):397-9
58. Stenfeldt C, Pacheco JM, Borca MV, Rodriguez LL, Arzt J. Morphologic and phenotypic characteristics of myocarditis in two pigs infected by foot-and mouth disease virus strains of serotypes O or A. Acta Vet Scand (2014) 56:42. doi:10.1186/s13028-014-0042-6
59. Gelmetti D, Meroni A, Brocchi E, Koenen F, Cammarata G. Pathogenesis of encephalomyocarditis experimental infection in young piglets: a potential animal model to study viral myocarditis. Vet Res (2006) 37(1):15-23. doi:10.1051/vetres:2005041
60. Gwathmey JK, Nakao S, Come PC, Goad ME, Serur JR, Als AV, et al. An experimental model of acute and subacute viral myocarditis in the pig. J Am Coll Cardiol (1992) 19(4):864-9. doi:10.1016/0735-1097(92)90533-S
61. Carocci M, Bakkali-Kassimi L. The encephalomyocarditis virus. Virulence (2012) 3(4):351-67. doi:10.4161/viru.20573
62. Toka FN, Golde WT. Cell mediated innate responses of cattle and swine are diverse during foot-and-mouth disease virus (FMDV) infection: a unique landscape of innate immunity. Immunol Lett (2013) 152(2):135-43. doi:10.1016/j.imlet.2013.05.007
63. Rigden RC, Carrasco CP, Summerfield A, KC MC. Macrophage phagocytosis of foot-and-mouth disease virus may create infectious carriers. Immunology (2002) 106(4):537-48. doi:10.1046/j.1365-2567.2002.01460.x
64. McCullough KC, Parkinson D, Crowther JR. Opsonization-enhanced phagocytosis of foot-and-mouth disease virus. Immunology (1988) 65(2):187-91
65. Mason PW, Grubman MJ, Baxt B. Molecular basis of pathogenesis of FMDV. Virus Res (2003) 91(1):9-32. doi:10.1016/S0168-1702(02)00257-5
66. Guzylack-Piriou L, Bergamin F, Gerber M, McCullough KC, Summerfield A. Plasmacytoid dendritic cell activation by foot-and-mouth disease virus requires immune complexes. Eur J Immunol (2006) 36(7):1674-83. doi:10.1002/eji.200635866
67. Diaz-San Segundo F, Rodriguez-Calvo T, de Avila A, Sevilla N. Immunosuppression during acute infection with foot-and-mouth disease virus in swine is mediated by IL-10. PLoS One (2009) 4(5):e5659. doi:10.1371/journal.pone.0005659
68. Nfon CK, Ferman GS, Toka FN, Gregg DA, Golde WT. Interferon-alpha production by swine dendritic cells is inhibited during acute infection with foot-and-mouth disease virus. Viral Immunol (2008) 21(1):68-77. doi:10.1089/vim.2007.0097
69. Nfon CK, Toka FN, Kenney M, Pacheco JM, Golde WT. Loss of plasmacytoid dendritic cell function coincides with lymphopenia and viremia during foot-and-mouth disease virus infection. Viral Immunol (2010) 23(1):29-41. doi:10.1089/vim.2009.0078
70. Valladeau J, Ravel O, Dezutter-Dambuyant C, Moore K, Kleijmeer M, Liu Y, et al. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity (2000) 12(1):71-81. doi:10.1016/S1074-7613(00)80160-0
71. Bautista EM, Ferman GS, Gregg D, Brum MC, Grubman MJ, Golde WT. Constitutive expression of alpha interferon by skin dendritic cells confers resistance to infection by foot-and-mouth disease virus. J Virol (2005) 79(8):4838-47. doi:10.1128/JVI.79.8.4838-4847.2005
72. Toka FN, Nfon C, Dawson H, Golde WT. Natural killer cell dysfunction during acute infection with foot-and-mouth disease virus. Clin Vaccine Immunol (2009) 16(12):1738-49. doi:10.1128/CVI.00280-09
73. Diaz-San Segundo F, Salguero FJ, de Avila A, de Marco MM, Sanchez-Martin MA, Sevilla N. Selective lymphocyte depletion during the early stage of the immune response to foot-and-mouth disease virus infection in swine. J Virol (2006) 80(5):2369-79. doi:10.1128/JVI.80.5.2369-2379.2006
74. Bautista EM, Ferman GS, Golde WT. Induction of lymphopenia and inhibition of T cell function during acute infection of swine with foot and mouth disease virus (FMDV). Vet Immunol Immunopathol (2003) 92(1-2):61-73. doi:10.1016/S0165-2427(03)00004-7
75. Joshi G, Sharma R, Kakker NK. Phenotypic and functional characterization of T-cells and in vitro replication of FMDV serotypes in bovine lymphocytes. Vaccine (2009) 27(48):6656-61. doi:10.1016/j.vaccine.2009.08.107
76. Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, Oldstone MB. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med (2006) 12(11):1301-9. doi:10.1038/nm1492
77. Der SD, Zhou A, Williams BR, Silverman RH. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A (1998) 95(26):15623-8. doi:10.1073/pnas.95.26.15623
78. Iversen MB, Ank N, Melchjorsen J, Paludan SR. Expression of type III interferon (IFN) in the vaginal mucosa is mediated primarily by dendritic cells and displays stronger dependence on NF-kappaB than type I IFNs. J Virol (2010) 84(9):4579-86. doi:10.1128/JVI.02591-09
79. Takaoka A, Yanai H. Interferon signalling network in innate defence. Cell Microbiol (2006) 8(6):907-22. doi:10.1111/j.1462-5822.2006.00716.x
80. Wu J, Chen ZJ. Innate immune sensing and signaling of cytosolic nucleic acids. Annu Rev Immunol (2014) 32:461-88. doi:10.1146/annurev-immunol-032713-120156
81. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol (2010) 11(5):373-84. doi:10.1038/ni.1863
82. Schneider WM, Chevillotte MD, Rice CM. Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol (2014) 32:513-45. doi:10.1146/annurev-immunol-032713-120231
83. Chinsangaram J, Piccone ME, Grubman MJ. Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. J Virol (1999) 73(12):9891-8
84. de Los Santos T, de Avila Botton S, Weiblen R, Grubman MJ. The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. J Virol (2006) 80(4):1906-14. doi:10.1128/JVI.80.4.1906-1914.2006
85. Chinsangaram J, Koster M, Grubman MJ. Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase. J Virol (2001) 75(12):5498-503. doi:10.1128/JVI.75.12.5498-5503.2001
86. Diaz-San Segundo F, Weiss M, Perez-Martin E, Koster MJ, Zhu J, Grubman MJ, et al. Antiviral activity of bovine type III interferon against foot-and-mouth disease virus. Virology (2011) 413(2):283-92. doi:10.1016/j.virol.2011.02.023
87. Kim SM, Park JH, Lee KN, Kim SK, You SH, Kim T, et al. Robust protection against highly virulent foot-and-mouth disease virus in swine by combination treatment with recombinant adenoviruses expressing porcine alpha and gamma interferons and multiple small interfering RNAs. J Virol (2015) 89(16):8267-79. doi:10.1128/JVI.00766-15
88. Moraes MP, de Los Santos T, Koster M, Turecek T, Wang H, Andreyev VG, et al. Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons. J Virol (2007) 81(13):7124-35. doi:10.1128/JVI.02775-06
89. Chinsangaram J, Moraes MP, Koster M, Grubman MJ. Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease. J Virol (2003) 77(2):1621-5. doi:10.1128/JVI.77.2.1621-1625.2003
90. Moraes MP, Chinsangaram J, Brum MC, Grubman MJ. Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine. Vaccine (2003) 22(2):268-79. doi:10.1016/S0264-410X(03)00560-7
91. Perez-Martin E, Diaz-San Segundo F, Weiss M, Sturza DF, Dias CC, Ramirez-Medina E, et al. Type III interferon protects swine against foot-and-mouth disease. J Interferon Cytokine Res (2014) 34(10):810-21. doi:10.1089/jir.2013.0112
92. Kim SM, Kim SK, Park JH, Lee KN, Ko YJ, Lee HS, et al. A recombinant adenovirus bicistronically expressing porcine interferon-alpha and interferon-gamma enhances antiviral effects against foot-and-mouth disease virus. Antiviral Res (2014) 104:52-8. doi:10.1016/j.antiviral.2014.01.014
93. Diaz-San Segundo F, Dias CC, Moraes MP, Weiss M, Perez-Martin E, Owens G, et al. Venezuelan equine encephalitis replicon particles can induce rapid protection against foot-and-mouth disease virus. J Virol (2013) 87(10):5447-60. doi:10.1128/JVI.03462-12
94. Honda K, Taniguchi T. IRFs: master regulators of signalling by toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol (2006) 6(9):644-58. doi:10.1038/nri1900
95. Marie I, Durbin JE, Levy DE. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J (1998) 17(22):6660-9. doi:10.1093/emboj/17.22.6660
96. Dias CC, Moraes MP, Weiss M, Diaz-San Segundo F, Perez-Martin E, Salazar AM, et al. Novel antiviral therapeutics to control foot-and-mouth disease. J Interferon Cytokine Res (2012) 32(10):462-73. doi:10.1089/jir.2012.0012
97. Ramirez-Carvajal L, Diaz-San Segundo F, Hickman D, Long CR, Zhu J, Rodriguez LL, et al. Expression of porcine fusion protein IRF7/3(5D) efficiently controls foot-and-mouth disease virus replication. J Virol (2014) 88(19):11140-53. doi:10.1128/JVI.00372-14